First Midwest Bank Trust Division’s Revance Therapeutics, Inc. RVNC Stock Holding History

First Midwest Bank Trust Division’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-23,171	Closed	-$657K	–	391
2020 Q4	$657K	Sell	23,171 -7,174	-24%	-$186K	0.1%	206
2020 Q3	$763K	Buy	+30,345	New	+$796K	0.12%	183
2019 Q4	–	Sell	-67,141	Closed	-$873K	–	380
2019 Q3	$873K	Sell	67,141 -37,322	-36%	-$457K	0.13%	175
2019 Q2	$1.35M	Buy	+104,463	New	+$1.32M	0.19%	135
2019 Q1	–	Sell	-20,399	Closed	-$411K	–	391
2018 Q4	$411K	Sell	20,399 -19,561	-49%	-$431K	0.06%	269
2018 Q3	$993K	Buy	39,960 +14,986	+60%	+$408K	0.13%	171
2018 Q2	$686K	Buy	+24,974	New	+$751K	0.1%	227

Other funds holding RVNC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First Midwest Bank Trust Division's RVNC Position: Q1 2021 in Review

First Midwest Bank Trust Division sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2021, closing a stake of 23,171 shares — an estimated $657K sold.

First Midwest Bank Trust Division first reported a position in RVNC in Q2 2018 and held it in 7 quarters. The position peaked at $1.35M in Q2 2019. 149 funds tracked by Wall St. Rank hold RVNC as of Q1 2021.

First Midwest Bank Trust Division reported no remaining Revance Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
First Midwest Bank Trust Division sold 23,171 Revance Therapeutics, Inc. shares in Q1 2021, an estimated $657K.
First Midwest Bank Trust Division first reported a position in Revance Therapeutics, Inc. in Q2 2018 and held it in 7 quarters.
First Midwest Bank Trust Division's Revance Therapeutics, Inc. position peaked at $1.35M in Q2 2019.
149 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q1 2021, filed 15 Apr 2021.